• Je něco špatně v tomto záznamu ?

Prognostic assessment of T-cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis

A. Trailin, E. Ali, W. Ye, S. Pavlov, L. Červenková, O. Vyčítal, F. Ambrozkiewicz, P. Hošek, O. Daum, V. Liška, K. Hemminki

. 2025 ; 156 (6) : 1282-1292. [pub] 20241107

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009492

Grantová podpora
NU21-03-00506 Agentura Pro Zdravotnický Výzkum České Republiky

Prognostic value of T-cells between primary colorectal cancer (pCRC) and its paired synchronous and metachronous liver metastasis (LM) is underinvestigated and is the subject of the present study. We enrolled into this retrospective cohort study patients, who underwent resection of both pCRC and synchronous LM (N = 55) or metachronous LM (N = 44). After immunohistochemical staining for CD3+, CD8+, and CD45R0+ whole slides were scanned and T-cell densities were quantified using QuPath software in tumor center (TC), inner margin (IM), outer margin (OM), and peritumor zone (PT) of pCRC and LM. High densities of CD8+ T-cells in TC, OM and PT of synchronous LM were associated with longer disease-free survival (DFS). Greater densities of CD3+ T-cells in IM and PT and CD8+ T-cells in IM, OM and PT in synchronous LM over pCRC were associated with longer DFS. Greater densities of CD8+ T-cells in the TC and IM and CD3+ T-cells in the IM of pCRC were found in the metachronous over synchronous group. The first novel finding demonstrated that high density of CD8+ T cells in synchronous LM were associated with favorable outcome. The second finding of high CD8+ cell density in pCRC in metachronous over synchronous CRC may provide a mechanistic basis for the delay of metastatic spread. Both findings could be applied clinically with own reference values.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009492
003      
CZ-PrNML
005      
20250429134636.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ijc.35252 $2 doi
035    __
$a (PubMed)39508720
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Trailin, Andriy $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $1 https://orcid.org/0000000188880759
245    10
$a Prognostic assessment of T-cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis / $c A. Trailin, E. Ali, W. Ye, S. Pavlov, L. Červenková, O. Vyčítal, F. Ambrozkiewicz, P. Hošek, O. Daum, V. Liška, K. Hemminki
520    9_
$a Prognostic value of T-cells between primary colorectal cancer (pCRC) and its paired synchronous and metachronous liver metastasis (LM) is underinvestigated and is the subject of the present study. We enrolled into this retrospective cohort study patients, who underwent resection of both pCRC and synchronous LM (N = 55) or metachronous LM (N = 44). After immunohistochemical staining for CD3+, CD8+, and CD45R0+ whole slides were scanned and T-cell densities were quantified using QuPath software in tumor center (TC), inner margin (IM), outer margin (OM), and peritumor zone (PT) of pCRC and LM. High densities of CD8+ T-cells in TC, OM and PT of synchronous LM were associated with longer disease-free survival (DFS). Greater densities of CD3+ T-cells in IM and PT and CD8+ T-cells in IM, OM and PT in synchronous LM over pCRC were associated with longer DFS. Greater densities of CD8+ T-cells in the TC and IM and CD3+ T-cells in the IM of pCRC were found in the metachronous over synchronous group. The first novel finding demonstrated that high density of CD8+ T cells in synchronous LM were associated with favorable outcome. The second finding of high CD8+ cell density in pCRC in metachronous over synchronous CRC may provide a mechanistic basis for the delay of metastatic spread. Both findings could be applied clinically with own reference values.
650    _2
$a lidé $7 D006801
650    12
$a nádory jater $x sekundární $x imunologie $x patologie $7 D008113
650    12
$a kolorektální nádory $x patologie $x imunologie $7 D015179
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a senioři $7 D000368
650    _2
$a CD8-pozitivní T-lymfocyty $x imunologie $7 D018414
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a dospělí $7 D000328
650    _2
$a mnohočetné primární nádory $x patologie $x imunologie $7 D009378
650    _2
$a T-lymfocyty $x imunologie $x patologie $7 D013601
650    _2
$a sekundární malignity $x patologie $7 D016609
650    _2
$a tumor infiltrující lymfocyty $x imunologie $x patologie $7 D016246
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ali, Esraa $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Ye, Wenjing $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Pavlov, Sergii $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Červenková, Lenka $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Vyčítal, Ondřej $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Ambrozkiewicz, Filip $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Hošek, Petr $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Daum, Ondřej $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Liška, Václav $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Hemminki, Kari $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
773    0_
$w MED00002298 $t International journal of cancer $x 1097-0215 $g Roč. 156, č. 6 (2025), s. 1282-1292
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39508720 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134631 $b ABA008
999    __
$a ok $b bmc $g 2311088 $s 1246573
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 156 $c 6 $d 1282-1292 $e 20241107 $i 1097-0215 $m International journal of cancer $n Int J Cancer $x MED00002298
GRA    __
$a NU21-03-00506 $p Agentura Pro Zdravotnický Výzkum České Republiky
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...